Anti-PI 3 Kinase p85 alpha + Gamma 抗体
Anti-PI 3 Kinase p85 alpha + Gamma antibody
3
(2 Reviews)
|
(12 Publications)
Rabbit Polyclonal PI 3 Kinase p85 alpha antibody. Suitable for WB, IHC-P, ICC/IF and reacts with African green monkey, Human samples. Cited in 12 publications. Immunogen corresponding to Synthetic Peptide within Human PIK3R1.
別名を表示する
GRB1, PIK3R1, Phosphatidylinositol 3-kinase regulatory subunit alpha, PI3-kinase regulatory subunit alpha, PI3K regulatory subunit alpha, PtdIns-3-kinase regulatory subunit alpha, Phosphatidylinositol 3-kinase 85 kDa regulatory subunit alpha, PI3-kinase subunit p85-alpha, PtdIns-3-kinase regulatory subunit p85-alpha
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-PI 3 Kinase p85 alpha + Gamma antibody (AB74136)
Immunofluorescence analysis of HeLa cells using ab74136, at 1/500 dilution, in the presence (right panel) or absence (left panel) of immunising peptide.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PI 3 Kinase p85 alpha + Gamma antibody (AB74136)
Immunohistochemical analysis of paraffin-embedded human breast carcinoma tissue using ab74136, at 1/50 dilution, in the presence (right panel) or absence (left panel) of immunising peptide.
- ICC/IF
AbReview17333****
Immunocytochemistry/ Immunofluorescence - Anti-PI 3 Kinase p85 alpha + Gamma antibody (AB74136)
ab74136 at 1/200 dilution staining PI 3 Kinase p85 alpha + Gamma in mouse embryonic stem cells by Immunocytochemistry/ Immunofluorescence. Cells were fixed in paraformaldehyde, permeabilized in 1 : 1 methanol, acetone and blocked in 1% serum for 30 minutes at 25°C. The primary antibody was used at 1/100 dilution in Goat block dillution buffer and incubated with sample at 25°C for 1 hours. An Alexa Fluor® 488 conjugated Goat polyclonal to rabbit IgG (H+L) was used as secondary at 1/500 dilution.
- WB
Unknown
Western blot - Anti-PI 3 Kinase p85 alpha + Gamma antibody (AB74136)
All lanes:
Western blot - Anti-PI 3 Kinase p85 alpha + Gamma antibody (ab74136) at 1/500 dilution
Lane 1:
Extracts from COS7 cells, treated with H<sub>2</sub>O<sub>2</sub> (100µM, 30mins) at 5 µg
Lane 2:
Extracts from COS7 cells, treated with H<sub>2</sub>O<sub>2</sub> (100µM, 30mins) at 5 µg with immunising peptide
Predicted band size: 84 kDa
Observed band size: 70 kDa,84 kDa
false
Reactivity data
出荷温度及び保存条件
製品の状態
精製方法
バッファー組成
出荷温度
短期保存温度
長期保存温度
保管に関する情報
補足情報
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The PI 3 Kinase p85 alpha + Gamma is an important regulator in signal transduction pathways and forms a heterodimer complex with p110 catalytic subunits. This kinase complex is activated by various growth factors and hormones through receptor tyrosine kinases. Upon activation PI3K phosphorylates phosphatidylinositol (45)-bisphosphate (PIP2) to produce phosphatidylinositol (345)-trisphosphate (PIP3) an essential second messenger that recruits downstream signaling proteins like AKT to the plasma membrane. This signal cascade regulates numerous cellular functions affecting homeostasis and adaptive responses.
Pathways
The PI 3 Kinase p85 alpha + Gamma plays a significant role in the PI3K/AKT/mTOR and MAPK signaling pathways. These pathways are essential in controlling cell metabolism survival and growth. Within these cascades PI3K phosphorylates PIP2 to PIP3 creating a docking site for AKT which subsequently becomes activated and relays signals to downstream effectors including mTOR and GSK-3β. The proper functioning of these pathways is necessary for maintaining cellular equilibrium and their dysregulation might lead to pathological conditions.
製品プロトコール
- Visit the General protocols
- Visit the Troubleshooting
ターゲットの情報
追加のターゲット
文献 (12)
Recent publications for all applications. Explore the full list and refine your search
Evidence-based complementary and alternative medic 2020:1403572 PubMed32802113
2020
Applications
Unspecified application
Species
Unspecified reactive species
Evidence-based complementary and alternative medic 2020:4527283 PubMed32774416
2020
Applications
Unspecified application
Species
Unspecified reactive species
Bioscience reports 40: PubMed31904088
2020
Applications
Unspecified application
Species
Unspecified reactive species
Food & function 10:2161-2175 PubMed30938722
2019
Applications
Unspecified application
Species
Unspecified reactive species
Rejuvenation research 22:218-229 PubMed30215298
2018
Applications
Unspecified application
Species
Unspecified reactive species
Molecular medicine reports 16:7706-7714 PubMed28944880
2017
Applications
Unspecified application
Species
Unspecified reactive species
International journal of immunopathology and pharm 30:25-43 PubMed28124574
2017
Applications
Unspecified application
Species
Unspecified reactive species
International journal of immunopathology and pharm 29:734-741 PubMed27466310
2016
Applications
Unspecified application
Species
Unspecified reactive species
Biochemistry and biophysics reports 5:313-327 PubMed28955838
2016
Applications
Unspecified application
Species
Unspecified reactive species
British journal of cancer 110:1968-76 PubMed24595002
2014
Applications
Unspecified application
Species
Human
Abcam product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com